USA Biodefense Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biodefense market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biodefense market. Detailed analysis of key players, along with key growth strategies adopted by Biodefense industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • SIGA Technologies

    • Emergent BioSolutions

    • Bavarian Nordic

    • DynPort Vaccine Company

    • Altimmune

    • Ichor Medical Systems

    • Achaogen

    • Cleveland BioLabs

    • Alnylam Pharmaceuticals

    • Elusys Therapeutics

    By Type:

    • Anthrax

    • Smallpox

    • Botulism

    • Radiation/Nuclear

    • Others

    By End-User:

    • Military Market

    • Civilian Market

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biodefense Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Biodefense Market Size and Growth Rate of Anthrax from 2016 to 2027

      • 1.3.2 USA Biodefense Market Size and Growth Rate of Smallpox from 2016 to 2027

      • 1.3.3 USA Biodefense Market Size and Growth Rate of Botulism from 2016 to 2027

      • 1.3.4 USA Biodefense Market Size and Growth Rate of Radiation/Nuclear from 2016 to 2027

      • 1.3.5 USA Biodefense Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Biodefense Market Size and Growth Rate of Military Market from 2016 to 2027

      • 1.4.2 USA Biodefense Market Size and Growth Rate of Civilian Market from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biodefense Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biodefense by Major Types

      • 3.4.1 Market Size and Growth Rate of Anthrax

      • 3.4.2 Market Size and Growth Rate of Smallpox

      • 3.4.3 Market Size and Growth Rate of Botulism

      • 3.4.4 Market Size and Growth Rate of Radiation/Nuclear

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Biodefense Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biodefense by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biodefense in Military Market

      • 4.4.2 Market Size and Growth Rate of Biodefense in Civilian Market

    5 Market Analysis by Regions

    • 5.1 USA Biodefense Production Analysis by Regions

    • 5.2 USA Biodefense Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Biodefense Landscape Analysis

    • 6.1 West USA Biodefense Landscape Analysis by Major Types

    • 6.2 West USA Biodefense Landscape Analysis by Major End-Users

    7 South USA Biodefense Landscape Analysis

    • 7.1 South USA Biodefense Landscape Analysis by Major Types

    • 7.2 South USA Biodefense Landscape Analysis by Major End-Users

    8 Middle West USA Biodefense Landscape Analysis

    • 8.1 Middle West USA Biodefense Landscape Analysis by Major Types

    • 8.2 Middle West USA Biodefense Landscape Analysis by Major End-Users

    9 Northeast USA Biodefense Landscape Analysis

    • 9.1 Northeast USA Biodefense Landscape Analysis by Major Types

    • 9.2 Northeast USA Biodefense Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 SIGA Technologies

        • 10.1.1 SIGA Technologies Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Emergent BioSolutions

        • 10.2.1 Emergent BioSolutions Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Bavarian Nordic

        • 10.3.1 Bavarian Nordic Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 DynPort Vaccine Company

        • 10.4.1 DynPort Vaccine Company Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Altimmune

        • 10.5.1 Altimmune Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Ichor Medical Systems

        • 10.6.1 Ichor Medical Systems Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Achaogen

        • 10.7.1 Achaogen Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Cleveland BioLabs

        • 10.8.1 Cleveland BioLabs Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Alnylam Pharmaceuticals

        • 10.9.1 Alnylam Pharmaceuticals Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Elusys Therapeutics

        • 10.10.1 Elusys Therapeutics Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Biodefense Market Size and Growth Rate of Anthrax from 2016 to 2027

    • Figure USA Biodefense Market Size and Growth Rate of Smallpox from 2016 to 2027

    • Figure USA Biodefense Market Size and Growth Rate of Botulism from 2016 to 2027

    • Figure USA Biodefense Market Size and Growth Rate of Radiation/Nuclear from 2016 to 2027

    • Figure USA Biodefense Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Biodefense Market Size and Growth Rate of Military Market from 2016 to 2027

    • Figure USA Biodefense Market Size and Growth Rate of Civilian Market from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Biodefense Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biodefense Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biodefense

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biodefense by Different Types from 2016 to 2027

    • Table Consumption Share of Biodefense by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Anthrax

    • Figure Market Size and Growth Rate of Smallpox

    • Figure Market Size and Growth Rate of Botulism

    • Figure Market Size and Growth Rate of Radiation/Nuclear

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biodefense by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biodefense by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Military Market

    • Figure Market Size and Growth Rate of Civilian Market

    • Table USA Biodefense Production by Regions

    • Table USA Biodefense Production Share by Regions

    • Figure USA Biodefense Production Share by Regions in 2016

    • Figure USA Biodefense Production Share by Regions in 2021

    • Figure USA Biodefense Production Share by Regions in 2027

    • Table USA Biodefense Consumption by Regions

    • Table USA Biodefense Consumption Share by Regions

    • Figure USA Biodefense Consumption Share by Regions in 2016

    • Figure USA Biodefense Consumption Share by Regions in 2021

    • Figure USA Biodefense Consumption Share by Regions in 2027

    • Table West USA Biodefense Consumption by Types from 2016 to 2027

    • Table West USA Biodefense Consumption Share by Types from 2016 to 2027

    • Figure West USA Biodefense Consumption Share by Types in 2016

    • Figure West USA Biodefense Consumption Share by Types in 2021

    • Figure West USA Biodefense Consumption Share by Types in 2027

    • Table West USA Biodefense Consumption by End-Users from 2016 to 2027

    • Table West USA Biodefense Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Biodefense Consumption Share by End-Users in 2016

    • Figure West USA Biodefense Consumption Share by End-Users in 2021

    • Figure West USA Biodefense Consumption Share by End-Users in 2027

    • Table South USA Biodefense Consumption by Types from 2016 to 2027

    • Table South USA Biodefense Consumption Share by Types from 2016 to 2027

    • Figure South USA Biodefense Consumption Share by Types in 2016

    • Figure South USA Biodefense Consumption Share by Types in 2021

    • Figure South USA Biodefense Consumption Share by Types in 2027

    • Table South USA Biodefense Consumption by End-Users from 2016 to 2027

    • Table South USA Biodefense Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Biodefense Consumption Share by End-Users in 2016

    • Figure South USA Biodefense Consumption Share by End-Users in 2021

    • Figure South USA Biodefense Consumption Share by End-Users in 2027

    • Table Middle West USA Biodefense Consumption by Types from 2016 to 2027

    • Table Middle West USA Biodefense Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Biodefense Consumption Share by Types in 2016

    • Figure Middle West USA Biodefense Consumption Share by Types in 2021

    • Figure Middle West USA Biodefense Consumption Share by Types in 2027

    • Table Middle West USA Biodefense Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Biodefense Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Biodefense Consumption Share by End-Users in 2016

    • Figure Middle West USA Biodefense Consumption Share by End-Users in 2021

    • Figure Middle West USA Biodefense Consumption Share by End-Users in 2027

    • Table Northeast USA Biodefense Consumption by Types from 2016 to 2027

    • Table Northeast USA Biodefense Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Biodefense Consumption Share by Types in 2016

    • Figure Northeast USA Biodefense Consumption Share by Types in 2021

    • Figure Northeast USA Biodefense Consumption Share by Types in 2027

    • Table Northeast USA Biodefense Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Biodefense Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Biodefense Consumption Share by End-Users in 2016

    • Figure Northeast USA Biodefense Consumption Share by End-Users in 2021

    • Figure Northeast USA Biodefense Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of SIGA Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIGA Technologies

    • Figure Sales and Growth Rate Analysis of SIGA Technologies

    • Figure Revenue and Market Share Analysis of SIGA Technologies

    • Table Product and Service Introduction of SIGA Technologies

    • Table Company Profile and Development Status of Emergent BioSolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions

    • Table Product and Service Introduction of Emergent BioSolutions

    • Table Company Profile and Development Status of Bavarian Nordic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic

    • Figure Sales and Growth Rate Analysis of Bavarian Nordic

    • Figure Revenue and Market Share Analysis of Bavarian Nordic

    • Table Product and Service Introduction of Bavarian Nordic

    • Table Company Profile and Development Status of DynPort Vaccine Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DynPort Vaccine Company

    • Figure Sales and Growth Rate Analysis of DynPort Vaccine Company

    • Figure Revenue and Market Share Analysis of DynPort Vaccine Company

    • Table Product and Service Introduction of DynPort Vaccine Company

    • Table Company Profile and Development Status of Altimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune

    • Figure Sales and Growth Rate Analysis of Altimmune

    • Figure Revenue and Market Share Analysis of Altimmune

    • Table Product and Service Introduction of Altimmune

    • Table Company Profile and Development Status of Ichor Medical Systems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ichor Medical Systems

    • Figure Sales and Growth Rate Analysis of Ichor Medical Systems

    • Figure Revenue and Market Share Analysis of Ichor Medical Systems

    • Table Product and Service Introduction of Ichor Medical Systems

    • Table Company Profile and Development Status of Achaogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Achaogen

    • Figure Sales and Growth Rate Analysis of Achaogen

    • Figure Revenue and Market Share Analysis of Achaogen

    • Table Product and Service Introduction of Achaogen

    • Table Company Profile and Development Status of Cleveland BioLabs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cleveland BioLabs

    • Figure Sales and Growth Rate Analysis of Cleveland BioLabs

    • Figure Revenue and Market Share Analysis of Cleveland BioLabs

    • Table Product and Service Introduction of Cleveland BioLabs

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Elusys Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elusys Therapeutics

    • Figure Sales and Growth Rate Analysis of Elusys Therapeutics

    • Figure Revenue and Market Share Analysis of Elusys Therapeutics

    • Table Product and Service Introduction of Elusys Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.